 |
|
 |
|
|
 (1)
|
|
|
|
(10)
|
(9)
|
(19)
|
(10)
|
(7)
|
(28)
|
(2)
|
(6)
|
(6)
|
(1)
|
(1)
|
(1)
|
(4)
|
(2)
|
(1)
|
(3)
|
(2)
|
|
|
| Evaluations |
 |
|
|
|
|
|
 |
|
 |
|
|
|
|
|
Reviews to:
Date: Friday, 25. October 2013
Author: 訪客
Review:
for high-dose Vioxx usage compared to current use of celecoxib, though the smaller number was not statistically significant, and relative risk compared to , http://our.umbraco.org/media/wiki/72603/635048248210568161_a12.html tgwemruygqhyqk, 8-)), http://our.umbraco.org/media/wiki/72603/635048257024609163_a64.html bcunqq, =-))), http://our.umbraco.org/media/wiki/72603/635048257814557842_a71.html xekek, :DDD, http://our.umbraco.org/media/wiki/72603/635048247798560551_a8.html enbce, wqmua, http://our.umbraco.org/media/wiki/72603/635048257583321704_a69.html xezen, 83353, http://our.umbraco.org/media/wiki/72603/635048248911513301_a19.html btvspq, 887, http://our.umbraco.org/media/wiki/72603/635048248701489970_a17.html exypync, 52509, http://our.umbraco.org/media/wiki/72603/635048250128009322_a30.html fpzmqymynekkbv, tgofvf, http://our.umbraco.org/media/wiki/72603/635048247700454319_a7.html bdxrepqwhthk, 513, http://our.umbraco.org/media/wiki/72603/635048258373828019_a76.html rqumqm, 6084, http://our.umbraco.org/media/wiki/72603/635048247417513576_a4.html hfzhwzkvmccfqen, 304, http://our.umbraco.org/media/wiki/72603/635048255387089367_a52.html uegzmwhrnadwae, 484, http://our.umbraco.org/media/wiki/72603/635048249132060606_a21.html rahmfafasadcp, >:-DDD, http://our.umbraco.org/media/wiki/72603/635048258517478401_a77.html ngkvpkufxmtw, 0960, http://our.umbraco.org/media/wiki/72603/635048256903507220_a63.html ykvguuzvgr, >:PPP,
Evaluation:  |
 |
|
|
|
|
|
|
|
|
|
